More care.
In your
practice.

Transcranial magnetic stimulation (TMS) uses magnetic pulses from a coil near the scalp to stimulate brain regions involved in mood. It is noninvasive and does not require anesthesia.

Certain devices are FDA-cleared for depression, including cases where antidepressants have not provided enough benefit. A qualified clinician assesses whether it belongs in an individual’s care.

TMS has been studied in both settings, with encouraging findings in small studies. Perinatal evidence is still developing; it should not be treated as equivalent to the broader evidence for depression.

Suitability requires review of the patient, device labeling, protocol, benefits, risks, and alternatives by clinicians with relevant TMS and perinatal mental health expertise.

The patient remains awake and may feel tapping at the scalp. Sessions commonly last around 3–40 minutes; conventional courses often involve five visits a week for four to six weeks.

Assessment, setup, and monitoring also need time in the schedule. Some protocols use different schedules, so planning must reflect the selected device and prescribed protocol.

Headache and scalp discomfort can occur; seizures are a rare risk. Clinical assessment includes reviewing implants, seizure risk, medications, and medical history.

Device-specific screening, hearing protection, patient monitoring, and an emergency response plan belong in the service workflow. These responsibilities remain with appropriately qualified and trained clinical personnel.

For a suitable practice, an onsite service could broaden depression-care options, reduce the need for some outside referrals, and create an additional outpatient service line.

Hermana’s focus is connecting that service to the wider care pathway. The fit depends on patient demand, clinical capacity, costs, and reimbursement.

Our planned model combines self-contained TMS installations using third-party technology with care navigation and coordinated workflows. Hermana brings existing treatments and protocols together; we do not manufacture the devices.

A practice review would cover the treatment room, equipment and power requirements, referral and assessment pathways, scheduling, and follow-up. The device, clinical responsibilities, training, and support arrangements would be specified before an installation agreement.

A TMS service needs an appropriately licensed prescriber and trained treatment personnel working under the required supervision. Device-specific training, patient monitoring, documentation, and emergency procedures are part of that responsibility.

The partnership discussion would establish who supplies each role, clinical coverage, and training, subject to local and payer requirements. Workflow automation supports coordination; it does not replace clinical supervision.

A practice-level review should cover equipment, room use, staff time, training, maintenance, expected volume, and payer mix. Hermana’s commercial terms would be specified before any commitment.

Coverage is plan- and indication-specific. Coverage for qualifying major depression does not guarantee perinatal coverage. Patient eligibility, prior authorization, provider requirements, and documentation need verification before projecting revenue.

No existing TMS service is needed to express interest. Share your practice name, location, and business contact details. A first conversation can focus on patient demand, available space, clinical coverage, and the kind of partnership you want.

Registering interest is free and carries no obligation. Please do not send patient information through this form.